- Experienced line manager working as global Vice President Translational Science line managing a division of 150 scientists delivering excellent outcome and step change in productivity (up 50% over 3 years). Director level appointments for 10 years.
- Extensive knowledge in driving strategy development and delivering profound change through chairing multiple global cross functional scientific groups and appointment as global head of strategy for oncology and infection. This resulted in, for example, cross disease area exploitation of drug projects and focus on targeting mechanisms driving molecularly defined cancers
- Strong scientific background (MD, PhD) as evident by 80 peer-reviewed publications, professorship in Physiology and Editor-in-chief for an Elsevier journal.
Education, research, positions:
2011- CEO, Innoext
2010-2011 Global Vice President Strategy, AstraZeneca Oncology (interim)
2009-2010 Global Head of Strategy & Planning, AstraZeneca Oncology/Infect
2006-2008 Global Vice President Translational Science DECS, AstraZeneca
2005-2008 Chair of multiple global AstraZeneca improvement projects (Stem
cells, Bioscience, Translational science)
1998-2008 Professor, Department of Physiology, Faculty of Medicine,
Sahlgrenska Academy
1999-2006 Director AstraZeneca Transgenics & Comparative Genomics
1996-1999 Director of Astra Transgenic Centre
1990-1996 Principal investigator at Sahlgrenska Academy, Department of
Physiology, Faculty of Medicine
1990-1996 Independent consultant
1992 Associate professor (Docent) in physiology, Faculty of Medicine,
Gotheburg University (GU)
1990-1992 Assistant professor
1990 Thesis presented. Degree: Ph D at the Faculty of Medicine, GU
1984-1990 Graduate student in Physiology, Faculty of Medicine, GU
1980‑1985 Medical studies. Degree: MD 1985